approximately one third of cases, with prevalence being higher among working-age adults [2] [3] [4] [5] • • Patients with IBS-D commonly experience multiple bothersome symptoms including diarrhoea, abdominal pain, urgency and bloating; symptoms can be mild and intermittent but can often be severe or continuous. 6, 7 IBS-D symptom severity is often evaluated based on frequency of symptoms and their impact on patients' daily lives • • The symptom burden of IBS-D is associated with significant impairments in patient health-related quality of life (HRQoL) as well as increased healthcare resource utilization (HCRU), including physician office visits and hospitalisations, and can also impair a patient's productivity and ability to work, resulting in substantial economic burden to the patient and society , which consists of 36 questions and includes the following eight health subscales: physical functioning, role/physical, bodily pain, general health, vitality/energy, social functioning, role/emotional, and mental health/ emotional well-being --Subscale scores are combined into physical component summary (PCS) and mental component summary (MCS) scores calculated as norm-based scores ranging from 0 to 100 (worldwide normative mean=50; standard deviation=10), with higher scores indicating better HRQoL • • The Work Productivity and Activity Impairment (WPAI) questionnaire 10 was used to assess absenteeism (work time missed), presenteeism (impairment at work/reduced on-the-job effectiveness), work productivity loss (overall work impairment/absenteeism plus presenteeism) and activity impairment due to health problems --WPAI outcomes were expressed as impairment percentages, with higher numbers indicating greater impairment and reduced productivity 
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